Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

Ensysce Biosciences, Inc.

(Exact Name of Each Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

		Security Type		Security Class Title		Fee Calculation or Carry Forward Rule		Amount Registered				Proposed Maximum Offering Price Per Unit				Maximum Aggregate Offering Price⁽¹⁾				Fee Rate⁽²⁾				Amount of Registration Fee ⁽²⁾				Carry Forward Form Type				Carry Forward File Number				Carry Forward Initial effective date				Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward
Newly Registered Securities
Fees to Be Paid		Equity		Common Stock, par value $0.0001 per share (“Common Stock”)⁽³⁾⁽⁴⁾		457(o)										$	5,000,000.00							$	738.00
		Other		Pre-funded Warrants to purchase Common Stock⁽⁴⁾		457(g)											(included above)
		Equity		Common Stock underlying the Pre-funded Warrants to purchase Common Stock⁽³⁾⁽⁴⁾		457(o)											(4	)							(4	)
		Other		Series B-1 Warrants to purchase Common Stock		457(g)											-								(5	)
		Equity		Common Stock underlying the Series B-1 Warrants to purchase Common Stock⁽³⁾		457(o)										$	5,000,000.00							$	738.00
		Other		Series B-2 Warrants to purchase Common Stock		457(g)											-								(5	)
		Equity		Common Stock underlying Series B-2 Warrants to purchase Common Stock⁽³⁾		457(o)										$	5,000,000.00							$	738.00
		Other		Placement Agent Warrants to purchase Common Stock		457(g)											-								(5	)(6)
		Equity		Common Stock underlying Placement Agent Warrants to purchase Common Stock(3)		457(o)										$	437,500.00							$	64.58

Fees Previously Paid																									-
Carry Forward Securities
Carry Forward Securities
		Total Offering Amounts														$	15,437,500.00							$	2,278.58
		Total Fees Previously Paid																							-
		Total Fee Offsets																							-
		Net Fee Due																						$	2,278.58

(1)	Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”)
(2)	The registration fee is calculated in accordance with Rule 457(o) under the Securities Act at a fee rate of 0.00014760 ($147.60 per $1 million).
(3)	Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant’s securities that become issuable by reason of any share splits, share dividends or similar transactions.
(4)	The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering and Common Stock issuable upon exercise of Series B-1 Warrants and Series B-2 Warrants. Accordingly, the proposed maximum aggregate offering price of the Common Stock and pre-funded warrants (including the Common Stock issuable upon exercise of the pre-funded warrants), if any, is $5,000,000.
(5)	No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act for the warrants because the warrants are being registered in the same registration statement as the common stock issuable upon exercise of the warrants.
(6)	Represents warrants issuable to the placement agent, or its designees, to purchase a number of shares of common stock equal to 7.0% of the shares of common stock sold in this offering (including the shares of common stock issuable upon the exercise of the pre-funded warrants), at an exercise price equal to 125% of the public offering price per share and accompanying warrants.